Related Experiment Video
Updated: Aug 4, 2026

Studying Cell Death Initiation Using a Digital Microscope
Published on: November 10, 2023
Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development
A Kruczynski1, C Etiévant, D Perrin
1Division of Experimental Cancer Research, Centre de Recherche Pierre Fabre, 17 avenue Jean Moulin, 81106 Castres, Cedex 06, France. anna.kruczynski@pierre-fabre.com
Abstract:
Vinflunine, the most recent Vinca alkaloid in clinical development, demonstrated superior antitumour activity to other Vincas in preclinical tumour models. This study aimed to define its molecular mechanisms of cell killing in both parental sensitive and vinflunine-resistant P388 leukaemia cells. Vinflunine treatment of these cells resulted in apoptosis characterized by DNA fragmentation and proteolytic cleavage of poly-(ADP-ribose) polymerase. Apoptosis-inducing concentrations of vinflunine caused c-Jun N-terminal kinase 1 stimulation, as well as caspases-3/7 activation. This activation of caspases and the induction of apoptosis could be inhibited by the caspase inhibitor acetyl-Asp-Glu-Val-Asp-aldehyde. Interestingly, the apoptosis signal triggered by vinflunine in these P388 cells was not mediated through Bcl-2 phosphorylation. In addition, when vinflunine resistance was developed in P388 cells, it was associated with resistance to vinflunine-induced apoptosis, as reflected by a loss of capacity to induce DNA fragmentation and PARP degradation, and characterized by increased levels of Bcl-2 and Bfl-1/A1. Therefore, these data indirectly implicate Bcl-2 and Bfl-1/A1 in vinflunine-induced cell death mechanisms.
Insights
Vinflunine induces apoptosis in leukemia cells by activating caspases and C-Jun N-terminal kinase 1. Resistance to vinflunine is linked to increased Bcl-2 and Bfl-1/A1 levels, suggesting their role in cell death.
Area of Science:
- Pharmacology
- Molecular Biology
- Cancer Research
Background:
- Vinflunine is a novel Vinca alkaloid with potent preclinical antitumour activity.
- Understanding the molecular mechanisms of vinflunine-induced cell death is crucial for its clinical application.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying vinflunine-induced apoptosis in P388 leukemia cells.
- To investigate the mechanisms of vinflunine resistance in P388 leukemia cells.
Main Methods:
- Induction of apoptosis and measurement of DNA fragmentation and poly-(ADP-ribose) polymerase (PARP) cleavage.
- Assessment of c-Jun N-terminal kinase 1 (JNK1) and caspase-3/7 activation.
- Development and characterization of vinflunine-resistant P388 cell lines, including analysis of Bcl-2 and Bfl-1/A1 protein levels.
Main Results:
- Vinflunine treatment induced apoptosis, characterized by DNA fragmentation and PARP cleavage.
- Apoptosis was associated with activation of JNK1 and caspases-3/7, which was reversible by a caspase inhibitor.
- Vinflunine-resistant cells exhibited reduced apoptosis induction and increased levels of Bcl-2 and Bfl-1/A1.
Conclusions:
- Vinflunine triggers apoptosis through caspase-dependent pathways involving JNK1 activation.
- Bcl-2 and Bfl-1/A1 proteins are implicated in the development of vinflunine resistance by inhibiting vinflunine-induced apoptosis.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Drugs that Destabilize Microtubules
Cellular Injury V: Apoptosis and Autophagy

